New Key Statistics Module, Z-Score and F-Score
TSXV:NGMD Key Ratios
Market Cap C$ M | 16.33 |
Enterprise Value C$ M | 26.25 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 25.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.04 |
Beneish M-Score | -2.12 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.00 |
EV-to-EBITDA | -4.44 |
PEG | -- |
Shares Outstanding M | 217.73 |
Net Margin (%) | -1,089.12 |
Operating Margin % | -849.02 |
Pre-tax Margin (%) | -1,084.27 |
Quick Ratio | 3.01 |
Current Ratio | 3.12 |
ROA % (ttm) | -95.87 |
ROE % (ttm) | -- |
ROIC % (ttm) | -90.57 |
Dividend Yield % | -- |
Altman Z-Score | -3.53 |
TSXV:NGMD Number of Guru Trades
TSXV:NGMD Volume of Guru Trades
Gurus Latest Trades with TSXV:NGMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:NGMD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NuGen Medical Devices Inc Insider Transactions
No Available Data